Attitude and Practices Regarding Use of Direct Acting Antiviral Agents (DAAs) in the Treatment of Hepatitis C among Health Care Practitioners “A Survey-based Study”
Nadia Saifullah, Dabeeran Zehra, Ambreen Wasim, Samia Saifullah, Urooj Zafar & Akhtar Ali · Journal of Pharmaceutical Research International · 2021
Approximately 3% of the world population has been known to be infected with HCV. Hepatitis C virus is a major etiological factor behind the development of liver diseases such as cirrhosis and hepatocellular carcinoma. Interferon-based therapy has remained as the mainstay treatmen...
Open access
Research Article
10.9734/jpri/2021/v33i30B31647